GB1343113A - Insulin derivatives - Google Patents
Insulin derivativesInfo
- Publication number
- GB1343113A GB1343113A GB1343113DA GB1343113A GB 1343113 A GB1343113 A GB 1343113A GB 1343113D A GB1343113D A GB 1343113DA GB 1343113 A GB1343113 A GB 1343113A
- Authority
- GB
- United Kingdom
- Prior art keywords
- amino group
- acyl
- protected
- acid
- chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1343113 Insulins NATIONAL RESEARCH DEVELOPMENT CORP 11 Nov 1970 [8 May 1970] 22342/70 Heading C2C A physiologically acceptable substantially pure mono-, di- or tri-substituted insulin in which the terminal amino group of the B-chain (B 1 -phenylalanine) is protected by an acyl or other blocking substituent containing up to 7C and the terminal amino group of the A-chain (A 1 -glycine) is either free or protected by an acyl or other blocking substituent containing no more than 4C and no free primary amino group is prepared by reacting an insulin with an acylating agent or other blocking reagent to acylate or otherwise block the amino group of the B 1 - amino acid and optionally block the A 1 and/or B 29 amino acid and separating the mono-, di- or trisubstituted product. The N-hydroxy succinimide esters of acetic acid and 2,2-dimethyl-3-formyl-L-thiazolidine-4-car boxylic acid are prepared. Pharmaceutical compositions contain the compounds of the invention in forms suitable for injection.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2234270 | 1970-05-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1343113A true GB1343113A (en) | 1974-01-10 |
Family
ID=10177851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1343113D Expired GB1343113A (en) | 1970-05-08 | 1970-11-11 | Insulin derivatives |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPS495356B1 (en) |
DE (1) | DE2023447A1 (en) |
GB (1) | GB1343113A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6869930B1 (en) | 1993-09-17 | 2005-03-22 | Novo Nordisk A/S | Acylated insulin |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011003820A1 (en) * | 2009-07-06 | 2011-01-13 | Sanofi-Aventis Deutschland Gmbh | Heat- and vibration-stable insulin preparations |
WO2018190125A1 (en) | 2017-04-13 | 2018-10-18 | 横河電機株式会社 | Confocal scanner, microscope system, and confocal microscope |
-
1970
- 1970-05-13 DE DE19702023447 patent/DE2023447A1/en active Pending
- 1970-05-15 JP JP4102170A patent/JPS495356B1/ja active Pending
- 1970-11-11 GB GB1343113D patent/GB1343113A/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6869930B1 (en) | 1993-09-17 | 2005-03-22 | Novo Nordisk A/S | Acylated insulin |
Also Published As
Publication number | Publication date |
---|---|
JPS495356B1 (en) | 1974-02-06 |
DE2023447A1 (en) | 1971-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1343113A (en) | Insulin derivatives | |
GB1271466A (en) | Thiocarbamic acid derivatives | |
GB1351024A (en) | Thiocetamide derivatives and preparation thereof | |
GB1109086A (en) | Polypeptides | |
GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
GB1278681A (en) | Peptides | |
IE34609L (en) | Therapeutic substituted thiazolidinedione | |
Ishihara et al. | Studies on actinoleukin, relation to echinomycin and levomycin | |
GB1332697A (en) | Benzodiazepine derivatives | |
GB1225019A (en) | Sulphonic acid esters | |
GB1327930A (en) | 1,4-benzodiazepine derivatives | |
GB1222294A (en) | Oxazinobenzodiazepine derivatives | |
GB1212137A (en) | Enzyme purification | |
GB1132397A (en) | Improvements in or relating to fluorene derivatives and the manufacture thereof | |
GB1509445A (en) | Benzodiazepine derivatives and a process for the preparation thereof | |
GB1146405A (en) | Alkene derivatives | |
GB1191800A (en) | 00-(beta-Diethylaminopropionyl)-2-Trifluoromethylphenothiazine Hydrochloride | |
GB1159232A (en) | Process for the production of High Molecular Weight Polyamides | |
GB1510431A (en) | Tri-cyclic compounds derived from phloroglucinal | |
GB1167455A (en) | Optical Resolution of Methionine Amide | |
IE37131L (en) | Insulin derivatives. | |
GB1143430A (en) | New cyclobutene derivative | |
GB1290468A (en) | ||
GB1433845A (en) | Phar | |
GB1185616A (en) | 2-Sulfanilamido-3-Halogeno-Pyridines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |